Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Diabetes

  Free Subscription


01.09.2025

1 Am Heart J
2 Am J Manag Care
1 Am J Ophthalmol
1 Atherosclerosis
1 Biochem Biophys Res Commun
1 Diabet Med
2 Diabetes
9 Diabetes Care
11 Diabetes Obes Metab
2 J Clin Endocrinol Metab
2 J Diabetes Complications
1 Kidney Int
3 Pediatr Diabetes
5 PLoS One
1 Retina


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am Heart J

  1. MAKUVIRE TT, Latif Z, Atwater S, Shah MK, et al
    Health Care Access and Risk Factor Control in US adults with Cardiovascular Disease from 2015 to 2023.
    Am Heart J. 2025 Jul 2:S0002-8703(25)00208-X. doi: 10.1016/j.ahj.2025.
    PubMed         Abstract available


    Am J Manag Care

  2. TREMBLAY ES, Argetsinger S, Zhang F, Ross-Degnan D, et al
    Trends in insulin out-of-pocket costs and use disparities, 2008-2021.
    Am J Manag Care. 2025;31:408-412.
    PubMed         Abstract available

  3. UKHANOVA M, Wozny JS, Truong CN, Ghosh L, et al
    Trends in glucagon-like peptide 1 receptor agonist prescribing patterns.
    Am J Manag Care. 2025;31:e228-e234.
    PubMed         Abstract available


    Am J Ophthalmol

  4. LAKHANI M, Kwan AT, Mihalache A, Popovic MM, et al
    Association of Glucagon-like Peptide-1 Receptor Agonists with Optic Nerve and Retinal Adverse Events: A Population-Based Observational Study Across 180 Countries.
    Am J Ophthalmol. 2025 May 16:S0002-9394(25)00239.
    PubMed         Abstract available


    Atherosclerosis

  5. WANG Y, Yang K, Jiang G, Zheng X, et al
    Twist1 promoting neointima hyperplasia after vascular injury in diabetes via regulating hyperglycemia-induced phenotype switching of vascular smooth muscle cells.
    Atherosclerosis. 2025;409:120496.
    PubMed         Abstract available


    Biochem Biophys Res Commun

  6. YU W, Xu H, Yuan X, Chen W, et al
    Cinnamaldehyde promotes diabetic wound healing via synergetic effects of AGE/RAGE-mediated macrophage polarization affecting fibroblast activation and angiogenesis, and Nrf2-dependent antioxidants.
    Biochem Biophys Res Commun. 2025;781:152519.
    PubMed         Abstract available


    Diabet Med

  7. CHUM C, McKeon A, Jenkins L, Le Gautier R, et al
    Acceptability of LISTEN for adults with diabetes distress: A qualitative study using the theoretical framework of acceptability to explore a brief problem-solving therapy intervention guided by diabetes health professionals.
    Diabet Med. 2025 Aug 29:e70128. doi: 10.1111/dme.70128.
    PubMed         Abstract available


    Diabetes

  8. FAGBEMI K, Avocegamou R, Yazdanpanah N, Yazdanpanah M, et al
    Metabolome-Wide Mendelian Randomization and Observational Study Reveal Causal Links Between Circulating Metabolites and Youth-Onset Type 2 Diabetes.
    Diabetes. 2025 Aug 27:db250093. doi: 10.2337/db25-0093.
    PubMed         Abstract available

  9. SIMS EK, Russell WE, Cuthbertson D, Skyler JS, et al
    Novel Approach for Assessing Outcomes of Type 1 Diabetes Prevention Trials Over a Fixed Time Interval.
    Diabetes. 2025 Aug 28:db250310. doi: 10.2337/db25-0310.
    PubMed         Abstract available


    Diabetes Care

  10. MARCH CA, Schoemer P, Naame E, Libman I, et al
    Are Pediatric Primary Care Providers Ready for Type 1 Diabetes Screening and Monitoring? A Survey From a Large, U.S. Pediatric Network.
    Diabetes Care. 2025 Aug 29:dc251292. doi: 10.2337/dc25-1292.
    PubMed        

  11. SNAITH JR, Narongkiatikhun P, Bjornstad P, Greenfield JR, et al
    Advancing Type 1 Diabetes Management: Integrating Novel Therapies, Technologies, and Adjunctive Approaches.
    Diabetes Care. 2025 Aug 29:dci250015. doi: 10.2337/dci25-0015.
    PubMed         Abstract available

  12. LI L, Li H
    Comment on Li et al. Transition of BMI Status From Childhood to Adulthood and Cardiovascular-Kidney-Metabolic Syndrome in Midlife: A 36-Year Cohort Study. Diabetes Care 2025;48:XXXX-XXXX.
    Diabetes Care. 2025 Aug 29:dc251860. doi: 10.2337/dc25-1860.
    PubMed        

  13. CLARKE PM, Hua X, Coleman RL, Chalmers J, et al
    International Variation in Case Fatality After Major Coronary or Cerebrovascular Events in Individuals With Type 2 Diabetes: Evidence From ADVANCE, TECOS, and EXSCEL.
    Diabetes Care. 2025 Aug 28:dc250541. doi: 10.2337/dc25-0541.
    PubMed         Abstract available

  14. SCHAEFER E, Barbaresko J, Roden M, Kuss O, et al
    Plant-Based Dietary Patterns Associated With Reduced Risk of All-Cause Mortality in Diabetes Subgroups: A Prospective Cohort Study From the UK Biobank.
    Diabetes Care. 2025 Aug 28:dc250344. doi: 10.2337/dc25-0344.
    PubMed         Abstract available

  15. KNOWLER WC, Pan Q, Shu S, Tripputi MT, et al
    Analysis of Long-term Follow-up of a Randomized Clinical Trial With Departures From Assigned Treatments: Estimation of Metformin Effects on Diabetes and Its Complications in the Diabetes Prevention Program Outcomes Study.
    Diabetes Care. 2025 Aug 26:dci250032. doi: 10.2337/dci25-0032.
    PubMed         Abstract available

  16. LARSSON JE, Stokholm L, Bek T, Andersen N, et al
    Sight-Threatening Diabetic Retinopathy During and After Pregnancy-A Nationwide Matched-Cohort Study.
    Diabetes Care. 2025 Aug 26:dc250758. doi: 10.2337/dc25-0758.
    PubMed         Abstract available

  17. KOBAYASHI E, Linden-Santangeli NJ, Chan N, Toomey CB, et al
    Longitudinal Metabolic Trajectories in Diabetes Prevention Program Participants Reveal Subgroups With Varying Micro- and Macrovascular Complication Risks.
    Diabetes Care. 2025 Aug 26:dc250866. doi: 10.2337/dc25-0866.
    PubMed         Abstract available

  18. DAGOGO-JACK S, Kazemi EJ, Doherty L, Srikanthan P, et al
    Impact of Parental or First-Degree Family History of Diabetes on Diabetes Incidence and Progression During Long-term Follow-up in the Diabetes Prevention Program Outcomes Study.
    Diabetes Care. 2025 Aug 29:dc250633. doi: 10.2337/dc25-0633.
    PubMed         Abstract available


    Diabetes Obes Metab

  19. LAVENS A, De Block C, Oriot P, Philips JC, et al
    Impact of the era of diabetes onset in a national care system on the prevalence of retinopathy and microalbuminuria in people living with type 1 diabetes 15 years post-diagnosis: A cross-sectional, real-world observational study.
    Diabetes Obes Metab. 2025 Aug 28. doi: 10.1111/dom.70049.
    PubMed         Abstract available

  20. KANAZAWA K, Hayashi K, Xinyi C, Hijikata M, et al
    Effectiveness and predictors of weight reduction with low-dose tirzepatide in Japanese patients with type 2 diabetes: A pilot retrospective cohort study.
    Diabetes Obes Metab. 2025 Aug 28. doi: 10.1111/dom.70062.
    PubMed        

  21. GIANGRECO F, Tura A, Parenti M, Cappelli S, et al
    GLP-1 receptor agonist therapy for relapsed diabetes following 6q24-related transient neonatal diabetes due to paternal uniparental disomy: A case report.
    Diabetes Obes Metab. 2025 Aug 27. doi: 10.1111/dom.70065.
    PubMed        

  22. JI L, Huang D, Lin X, Dong X, et al
    Efficacy and safety benefits of HR17031, a fixed-ratio combination of INS068 and noiiglutide, versus its components alone in Chinese patients with type 2 diabetes uncontrolled on oral antidiabetic drug(s): A phase 2, multicentre, open-label, randomise
    Diabetes Obes Metab. 2025 Aug 27. doi: 10.1111/dom.70036.
    PubMed         Abstract available

  23. VARGAS KG, Siemes B, Rutten T, Brockmeyer M, et al
    Assessment of precision medicine potential in diabetes mellitus: A meta-regression analysis of dose-dependent glycaemic control data from 44 randomised controlled trials.
    Diabetes Obes Metab. 2025 Aug 27. doi: 10.1111/dom.70066.
    PubMed        

  24. YEN FS, Wang SI, Hung YM, Hsu CC, et al
    Impact of glucagon-like peptide-1 receptor agonists on the incidence of inflammatory bowel disease in people with type 2 diabetes.
    Diabetes Obes Metab. 2025 Aug 27. doi: 10.1111/dom.70034.
    PubMed         Abstract available

  25. CAO Y, Widyahening I, Sun X, Li S, et al
    Pathophysiology of type 2 diabetes: A focus on the metabolic differences among southeast Asian, Chinese and Indian populations and how this impacts treatment.
    Diabetes Obes Metab. 2025 Aug 26. doi: 10.1111/dom.70060.
    PubMed         Abstract available

  26. YAU YK, Li M, Quan J, Grepin KA, et al
    Disrupted specialist outpatient services and alternative modes of service for patients with diabetes mellitus: A population-based, retrospective cohort study in Hong Kong.
    Diabetes Obes Metab. 2025 Aug 28. doi: 10.1111/dom.70069.
    PubMed         Abstract available

  27. ADOLFSSON P, Guerci B, Hartvig NV, Kaas A, et al
    Glycaemic control after connected insulin pen initiation in people living with diabetes: Results from a real-world setting.
    Diabetes Obes Metab. 2025 Aug 28. doi: 10.1111/dom.70051.
    PubMed         Abstract available

  28. WEN Y, Zeng S
    Advancing AI-driven biomarker discovery in diabetic nephropathy: A framework for robustness and interpretability.
    Diabetes Obes Metab. 2025 Aug 28. doi: 10.1111/dom.70087.
    PubMed        

  29. NUYUJUKIAN DS, Zhou JJ, Koska J, Reaven PD, et al
    Triglyceride variability and risk of heart failure events in type 2 diabetes: Results from the ACCORD trial.
    Diabetes Obes Metab. 2025 Aug 28. doi: 10.1111/dom.70083.
    PubMed        


    J Clin Endocrinol Metab

  30. HANSEN JV, Mathiesen DS, Christensen MB, Jorgensen NR, et al
    The separate and combined effects of GIP, GLP-1 and GLP-2 on markers of bone turnover in type 2 diabetes.
    J Clin Endocrinol Metab. 2025 Aug 29:dgaf482. doi: 10.1210.
    PubMed         Abstract available

  31. CHUBB SAP, Davis WA, Davis TME
    Effects of subclinical hypothyroidism on nephropathy complicating type 2 diabetes: The Fremantle Diabetes Study Phase II.
    J Clin Endocrinol Metab. 2025 Aug 29:dgaf485. doi: 10.1210.
    PubMed         Abstract available


    J Diabetes Complications

  32. HERMAN WH, Villatoro C, Joiner KL, McEwen LN, et al
    Corrigendum to "Retention and outcomes of National Diabetes Prevention Program enrollees and non-enrollees with prediabetes: The University of Michigan experience" [J. Diabetes Complicat. (2023) 108527].
    J Diabetes Complications. 2025 Aug 26:109157.
    PubMed        

  33. JI L, Abudulam R, Li M
    Letter to the Editor "The role of artificial intelligence in diabetic retinopathy screening in type 1 diabetes: A systematic review".
    J Diabetes Complications. 2025 Aug 25:109155.
    PubMed        


    Kidney Int

  34. YANG R, Hou Q, Chen R, Ma Z, et al
    Protein UHRF1-mediated dual dysregulation of molecular chaperone GRP78 induces endoplasmic reticulum stress and aggravates diabetic nephropathy.
    Kidney Int. 2025 Aug 25:S0085-2538(25)00654-4. doi: 10.1016/j.kint.2025.
    PubMed         Abstract available


    Pediatr Diabetes

  35. FAVEL K, Kelly MS, Lam STT, Bone JN, et al
    Prevalence and Risk Factors for Bladder and Bowel Dysfunction in Children With Type 1 Diabetes.
    Pediatr Diabetes. 2025;2025:5294835.
    PubMed         Abstract available

  36. GUDETA AN, Lind A, Girma A, Lempainen J, et al
    Diabetes, Celiac, and Thyroid-Related Autoantibodies in HLA Genotyped Ethiopian Children and Adolescents With Type 1 Diabetes: A Cross-Sectional Study.
    Pediatr Diabetes. 2025;2025:8258430.
    PubMed         Abstract available

  37. HOLDER M, Weiler J, Holl RW, Ehehalt S, et al
    Awareness Campaigns to Prevent Diabetic Ketoacidosis at Diabetes Onset Are Successful When Constantly Maintained: From Local to Federal State Results.
    Pediatr Diabetes. 2025;2025:5491154.
    PubMed         Abstract available


    PLoS One

  38. MARTIN S, Taylor SB, Pejhan S, Shideler BL, et al
    Correction: Immediate effects of visual feedback on the accuracy of foot landing adjustments in older people with diabetes mellitus: A cross-sectional study.
    PLoS One. 2025;20:e0331116.
    PubMed         Abstract available

  39. FENG J, He C, San H, Zhan M, et al
    The influence of stress hyperglycemia on consciousness disturbance and short- and long-term outcomes in stroke patients without documented diabetes: Differences between ischemic and hemorrhagic stroke.
    PLoS One. 2025;20:e0331077.
    PubMed         Abstract available

  40. BIRHANU N, Mamo G, Shiferaw GS, Gizachew D, et al
    Factors affecting diabetes related hospitalization and in-hospital outcomes of adults with diabetes in south Ethiopia: A prospective observational study.
    PLoS One. 2025;20:e0330735.
    PubMed         Abstract available

  41. SASONGKO MB, Febryanto GA, Haryanto S, Wardhana FS, et al
    Incidence and progression of diabetic retinopathy and blindness in Indonesian adults with type 2 diabetes.
    PLoS One. 2025;20:e0322093.
    PubMed         Abstract available

  42. YANG D, Shen Y, Shuai R
    Association between AST/ALT ratio and the risk of gestational diabetes mellitus in Korean pregnant women.
    PLoS One. 2025;20:e0331484.
    PubMed         Abstract available


    Retina

  43. SU T, Lai C, Du Z, Cao J, et al
    Retinal Photoreceptors and Arterioles Alterations Detected using Adaptive Optics Scanning Laser Ophthalmoscopy in Diabetes and Diabetic Retinopathy.
    Retina. 2025 Aug 21. doi: 10.1097/IAE.0000000000004647.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.